Advertisement

Ads Placeholder
Loading...

Telix Pharmaceuticals Limited

TLX•NASDAQ
Healthcare
Biotechnology
$9.78
$0.15(1.56%)
U.S. Market opens in 6h 31m

Telix Pharmaceuticals Limited (TLX) Stock Overview

Explore Telix Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.3B
P/E Ratio-436.77
EPS (TTM)$-0.02
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$6.39
3 Months$2.43
1 Year Target$0.00

TLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Telix Pharmaceuticals Limited (TLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -436.77 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.56%
5-Day Change
6.30%
1-Month Change
30.05%
3-Month Change
28.18%
6-Month Change
-4.49%
Year-to-Date (YTD) Change
28.35%
1-Year Change
-31.66%
3-Year Change
-35.45%
5-Year Change
-35.45%
All-Time (Max) Change
-35.45%

Contact Information

https://telixpharma.com
61 3 9093 3855
55 Flemington Road, North Melbourne, VIC, 3051

Company Facts

IPO DateNov 14, 2024
CountryAU
Actively Trading

Frequently Asked Questions